Tabuteau Herriot
Chief Executive Officer at AXSM
- Sold, on record
- $111M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Aug 6, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AXSMAxsome Therapeutics, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AXSMRoutineOct 8 2025
Sold 45,384 shares at $119.38 ($5.4M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 86.3% of holdings ($6.3M position)7,229 shares leftFiling
- 2 Form 4 sale AXSMRoutineNov 5 +28 days
Sold 163,939 shares at $133.07 ($21.8M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 95.8% of holdings ($22.8M position)7,229 shares leftFiling
- 3 Form 4 sale AXSMRoutineDec 4 +29 days
Sold 79,973 shares at $145.66 ($11.6M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 91.7% of holdings ($12.7M position)7,229 shares left1.3x usual sizeFiling
- 4 Form 4 sale AXSMRoutineJan 7 +34 days
Sold 139,414 shares at $171.30 ($23.9M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 95.1% of holdings ($25.1M position)7,229 shares left2x usual sizeFiling
- 5 Form 4 sale AXSMRoutineFeb 2 +26 days
Sold 32,410 shares at $185.60 ($6M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 81.8% of holdings ($7.4M position)7,229 shares left0.4x usual sizeFiling
- 6 Form 4 sale AXSMRoutineJun 9 +127 days
Sold 49,670 shares at $241.01 ($12M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 87.3% of holdings ($13.7M position)7,229 shares left0.7x usual sizeFiling
- 7 Form 4 sale AXSMRoutineJul 1 +22 days
Sold 49,666 shares at $240.25 ($11.9M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 87.3% of holdings ($13.7M position)7,229 shares left0.8x usual sizeFiling
- 8 Form 4 sale AXSMRoutineAug 6 +36 days
Sold 49,664 shares at $212.19 ($10.5M)
Tabuteau Herriot, Chief Executive Officer
10b5-1 planSold 87.3% of holdings ($12.1M position)7,229 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | AXSM | Chief Executive Officer | Form 4 sale | 49,664 | $10.5M | 87.3% | Routine | SEC |
| Jul 1, 2026 | AXSM | Chief Executive Officer | Form 4 sale | 49,666 | $11.9M | 87.3% | Routine | SEC |
| Jun 9, 2026 | AXSM | Chief Executive Officer | Form 4 sale | 49,670 | $12M | 87.3% | Routine | SEC |
| Feb 2, 2026 | AXSM | Chief Executive Officer | Form 4 sale | 32,410 | $6M | 81.8% | Routine | SEC |
| Jan 7, 2026 | AXSM | Chief Executive Officer | Form 4 sale | 139,414 | $23.9M | 95.1% | Routine | SEC |
| Dec 4, 2025 | AXSM | Chief Executive Officer | Form 4 sale | 79,973 | $11.6M | 91.7% | Routine | SEC |
| Nov 5, 2025 | AXSM | Chief Executive Officer | Form 4 sale | 163,939 | $21.8M | 95.8% | Routine | SEC |
| Oct 8, 2025 | AXSM | Chief Executive Officer | Form 4 sale | 45,384 | $5.4M | 86.3% | Routine | SEC |
| Sep 16, 2025 | AXSM | Chief Executive Officer | Form 4 sale | 62,880 | $7.4M | 89.7% | Routine | SEC |